CA2285605A1 - Gene ii de fanconi - Google Patents

Gene ii de fanconi Download PDF

Info

Publication number
CA2285605A1
CA2285605A1 CA002285605A CA2285605A CA2285605A1 CA 2285605 A1 CA2285605 A1 CA 2285605A1 CA 002285605 A CA002285605 A CA 002285605A CA 2285605 A CA2285605 A CA 2285605A CA 2285605 A1 CA2285605 A1 CA 2285605A1
Authority
CA
Canada
Prior art keywords
nucleic acid
cell
cell cycle
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285605A
Other languages
English (en)
Inventor
Manfred Kubbies
Andreas Machl
Simone Planitzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP1998/001994 external-priority patent/WO1998045428A1/fr
Publication of CA2285605A1 publication Critical patent/CA2285605A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un gène d'importance pathophysiologique associé à l'anémie de Fanconi, un polypeptide codé par celui-ci, un anticorps dirigé contre ce polypeptide, ainsi que l'utilisation pharmaceutique de l'acide nucléique, du polypeptide et de l'anticorps.
CA002285605A 1997-04-07 1998-04-06 Gene ii de fanconi Abandoned CA2285605A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97105688 1997-04-07
EP97105688.2 1997-04-07
PCT/EP1998/001994 WO1998045428A1 (fr) 1997-04-07 1998-04-06 Gene ii de fanconi

Publications (1)

Publication Number Publication Date
CA2285605A1 true CA2285605A1 (fr) 1998-10-15

Family

ID=8226668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285605A Abandoned CA2285605A1 (fr) 1997-04-07 1998-04-06 Gene ii de fanconi

Country Status (5)

Country Link
JP (1) JP2000510002A (fr)
AT (1) ATE213268T1 (fr)
AU (1) AU723543B2 (fr)
CA (1) CA2285605A1 (fr)
DE (1) DE59803082D1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364670T3 (es) * 2005-02-25 2011-09-12 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos ttk.

Also Published As

Publication number Publication date
DE59803082D1 (en) 2002-03-21
AU723543B2 (en) 2000-08-31
ATE213268T1 (de) 2002-02-15
JP2000510002A (ja) 2000-08-08
AU7429398A (en) 1998-10-30

Similar Documents

Publication Publication Date Title
JP2002502589A (ja) ４５個のヒト分泌タンパク質
CA2302644A1 (fr) Adnc etendus pour proteines secretees
JP2002521055A (ja) ９８個のヒト分泌タンパク質
HUT77578A (hu) A 10-es számú fibroblaszt növekedési faktor (FGF-10)
CA2300364A1 (fr) Polypeptides de tumeur de la prostate et compositions antigenes
US20040248256A1 (en) Secreted proteins and polynucleotides encoding them
JP2000507081A (ja) 肥満症を治療するための核酸
CA2441327A1 (fr) Compositions proteiques humaines riches en arginine-
JP2001514024A (ja) ５０個のヒト分泌タンパク質
JP2001514885A (ja) ７０個のヒト分泌タンパク質
EP1163338A2 (fr) Genes mesenchymateux humains et produits d'expression
KR100270348B1 (ko) 전사인자 에이피알에프
CA2554380C (fr) Gene mecp2e1
US6806351B2 (en) Secreted protein HBJFE12
US20040002449A1 (en) METH1 and METH2 polynucleotides and polypeptides
JP2003000270A (ja) 腫瘍抗原
US20020086848A1 (en) Fanconi-gene II
JPH04500603A (ja) クローン化腎炎抗原
AU723543B2 (en) Fanconi-gene II
JPH0892289A (ja) ヒトマッカード−ジョセフ病関連蛋白質、その蛋白質をコードするｃＤＮＡおよび遺伝子、そのＤＮＡまたは遺伝子を含むベクター、その発現ベクターで形質転換された宿主細胞、マッカード−ジョセフ病の診断方法および治療剤
JPH10504714A (ja) ヒトカリウムチャンネル１および２タンパク質
AU733462B2 (en) CYP7 promoter-binding factors
CA2267110A1 (fr) Gene i de fanconi
WO1999012952A1 (fr) Gene de mammifere de type rythme circadien
AU2002324283B2 (en) Variants and exons of the GlyT1 transporter

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued